GE HealthCare Technologies (GEHC) shares gained Wednesday after Jefferies analysts called the stock a “franchise pick” and made a bullish case for the company’s diagnostic imaging business.
Jefferies bumped its rating for the stock up to “buy” from “hold,” and raised its price target to $103 from $95, bringing it above the broader analyst consensus compiled by Visible Alpha at about $95. Shares rose 3.5% to close at $86.26 Wednesday and have added about 13% over the past year.
The analysts said the firm holds a leading position in the diagnostic imaging market, which they expect to grow by mid-single digits. GE HealthCare could also benefit from market consolidation, they noted.
Jefferies added that improving business in China "could be another icing on the cake.” China makes up 12% of the company’s sales, and GE HealthCare said in October that macroeconomic weakness in the country negatively impacted third-quarter sales.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。